卫星化学(002648 CH)：卫星化学：产品价差改善，新
项目打开成长空间—维持优于大市（Zhejiang Satellite
Chemical：Satellite Chemistry Product Price
Differentials Improve New Projects Unlock Growth
Potential—Maintain OP）
参阅附录。(Please see appendix for English translation of the disclaimer)
Equity  Asia Research
原材料：欧美库存高于往年，预计乙烷价格难以上涨
产品：主要用于消费、地产
价差：C2产品价差逐渐修复，未来仍有扩大空间
产能：连云港基地二阶段项目投产，乙烯消耗量超百万吨
原材料：丙烷与油价关联性强
产品：主要用于消费、地产
价差：C3产品价差处于底部，存在较大修复空间
资料来源：Wind，HTI
图2022年卫星化学营收结构
2022年营收结构：功能化学品占比5285%，高分子材料占比1987%，新能源材料占比063%，其他业务占比
2022年毛利结构：功能化学品占比6858%，高分子材料占比2779%，新能源材料占比145%，其他业务占比
图2022年卫星化学毛利结构
资料来源：百川盈孚，公司债券2020年跟踪评级报告，HTI
C3产业链：配套丙烯产能，具备成本优势
粮食、化肥、水泥等包装材料
家电、汽车、玩具、周转箱
公司打造C3一体化产业链，主要产品包括聚丙烯、丙烯酸、SAP、丙烯酸丁酯等、我们认为公司在长期生产中积
累了丰富经验，生产具备成本优势。
资料来源：百川盈孚，HTI
C2产业链：采用乙烷裂解制乙烯，具备多方面优势
公司采用乙烷裂解制乙烯，我们认为具有工艺流程短、占地面积小、装置投资少、乙烯收率高、生产成本低等诸
资料来源：卫星化学调研活动信息20220728，卫星化学调研活动信息20221025，丝路油气，HTI
打通乙烷物流线路，锁定低成本乙烷资源
公司打通乙烷供应链，锁定低成本乙烷资源
美国方面：当前美国仅有三个乙烷出口设施，公司拥有其中之一的股权并具有优先使用权。美国能源
管道投资大且资源稀缺；管道经过的所有土地与公用设施均涉及土地拥有人的同意。
船运方面：目前公司共有12艘VLEC船循环运输乙烷。
公司在建产能较多，打开未来成长空间
图2023-2024年公司在建产能较多
绿色新材料产业园一期：2023投产
平湖石化技改二期：部分装置正在开车
嘉兴基地乳液项目：加快推进
丁辛醇项目：2024投产
-烯烃综合利用高端新材料产业园：2024年底前开工
资料来源：卫星化学2021年11月4日及2023年5月5日投资者关系活动记录表，卫星化学关于
投资-烯烃综合利用高端新材料产业园项目的公告，卫星化学2022年报，HTI
40万吨聚苯乙烯、10万吨乙醇胺，15万吨电池级碳酸酯
18万吨丙烯酸与36万吨丙烯丁酯
90 万吨丙烯80 万吨多
碳醇8 万吨新戊二醇
80万吨PDH、80万吨丁辛醇和12万吨辛戊二醇
-烯烃综合利用高端新材
2024年底前开工50万吨阿尔法烯烃、60万吨POE、100万吨茂金属聚乙烯、
80万吨PVC、15万吨-烯烃、5万吨超高分子量聚乙烯
资料来源：Wind，HTI
图杨卫东夫妇为公司实控人，持有公司311%的股份（截止2023年6月30
杨卫东、杨亚珍夫妇为公司实控人，直接或间接持有公司311%的股份。公司股权结构较为集中
，有利于长期稳定发展。
资料来源：卫星化学股权激励草案，HTI
开展四次股权激励，助力业绩增长
公司董事、中高层管理人员、核心
业务（技术）人员24名
相比2013年，2014年净利润增长率不低于25%，ROE不低于14%
相比2013年，2015年净利润增长率不低于40%，ROE不低于14%
相比2013年，2016年净利润增长率不低于60%，ROE不低于14%
公司董事、高级管理人员、中层管
理人员及业务（技术）骨干23名
2016年净利润不低于1亿元
相比2016年，2017年净利润增长率不低于50%
相比2016年，2018年净利润增长率不低于100%
平湖基地45万吨PDH二期项目2018年12月31号前具备投料条件
平湖基地15万吨聚丙烯项目2019年12月31号前建成投产
相比2017年，2020年净利润增长率不低于60%
连云港石化中层管理人员、技术骨
干或公司董事、高级管理人员、技
术（业务）骨干105名
相比2020年，2021年营业收入增长率不低于50%
相比2020年，2022年营业收入增长率不低于80%
相比2020年，2023年营业收入增长率不低于120%
资料来源：Wind，卫星石化事业合伙人持股计划(草案)，HTI
推出事业合伙人计划，提高管理团队积极性
2021 年公司推出为期十年的事业合伙人计划，主要向公司核心员工及高管。以上一年度的净利润作为基数，依
据各年度的净利润增幅，确定专项基金提取比例。
2016-2022年，公司归母净利复合增速位为46%，我们认为未来公司达到合伙人计划目标概率较大。
净利润增长率低于10%
净利润增长率在10%（含）至30%之间
净利润增长率在30%（含）至50%之间
净利润增长率在50%（含）以上
图2016-2022年公司归母利润情况
归母净利润（亿元，左轴）
资料来源：Wind，HTI
图2016-2023公司单季度营收（亿元）
2022年底原料价格上涨，公司业绩处于底部
2021年以来，公司连云港石化C2一期、二期项目先后投放，推动公司营收增长。2021Q3-
2023Q1，公司营收规模稳定在90亿元左右，波动幅度不大。
2022年原油价格居高位，叠加国内PDH装置迎来扩产浪潮，丙烷价格居高不下。同时，俄乌冲
突造成欧洲出现能源危机，拉动全球天然气价格创历史新高，乙烷价格同步上涨。公司成本端压
力较大，盈利受到影响。2022年Q4，公司归母净利润为046亿元，处于历史底部，2023年Q1，
公司归母净利润为707亿元，环比有所改善。
图2016-2023公司单季度归母净利（亿元）
资料来源：Wind，Bloomberg ，saferack ，HTI
原料：乙烷价格与美国天然气价格相关性较强
乙烷是天然气加工副产品，价格与天然气走势相关性较强。根据wind和bloomberg数据计算，
2013年-2023年，美国天然气和乙烷价格的相关系数达到84%。
乙烷（美元吨左轴）
天然气（美元mmbtu，右轴）
资料来源：Wind，GIE，HTI
图美国天然气库存（亿立方米）
欧美库存高于往年，预计乙烷价格难以上涨
图欧洲天然气库存（TWH）
根据Wind和GIE统计，目前美国和欧洲天然气库存均处于历史高位，我们认为下半年欧美天然气
补库需求较弱，天然气及乙烷价格上涨压力较大。
美国：截至2023年第22周，美国天然气库存为722亿方，比历史同期平均水平高14%（美国天然
气库存历史同期平均水平为635亿方）
欧洲：截至2023年6月25日，欧洲天然气库存为858 TWH，比历史同期平均水平高29% （欧洲天
然气库存历史同期平均水平为667 TWH）
资料来源：百川盈孚，HTI
图C2产品与消费、地产密切相关
产品：主要用于消费、地产，受益需求复苏
C2产品应用领域与消费和地产密切相关，在消费复苏过程中有望涨价。
环氧乙烷：21%应用于洗涤、纺织领域，51%应用于建材领域
乙二醇：90%应用于纺服领域
苯乙烯：20%应用于汽车领域，30%应用于电器电子领域，28%应用于包装容器领域
HDPE：59%应用于包装膜领域
乙醇胺：36%应用于有机合成领域，27%应用于建材领域
资料来源：Wind，Bloomberg，HTI
C2产品价差逐渐修复，未来仍有扩大空间
图聚乙烯、环氧乙烷、聚醚大单体价差情况
图乙二醇、苯乙烯价差情况
聚乙烯：价差从2022 Q3 4990元吨扩大至2023 Q3 6667元吨，比2021平均水平（6802元吨）低2%。
环氧乙烷：价差从2022 Q3 4409元吨扩大至2023 Q3 4906元吨，比2021平均水平（6490元吨）低24%。
聚醚大单体：价差从2022 Q3 5637元吨扩大至2023 Q3 5836元吨，比2021平均水平（8153元吨）低28%。
乙二醇：价差从2022 Q3 2435元吨扩大至2023 Q3 2128元吨，比2021平均水平（4284元吨）低50%。
苯乙烯：价差从2022 Q3 2050元吨扩大至2023 Q3 3010元吨，比2021年平均水平（2809元吨）高7%。
资料来源：百川盈孚，卫星化学2023年5月4日投资者关系活动记录表，HTI
连云港基地二阶段项目投产，乙烯消耗量超百万吨
2022年，公司实现连云港基地二阶段项目一次性开车成功，新增年产40万吨HDPE、73万吨EO、
60万吨苯乙烯，对乙烯消耗量超百万吨
表连云港基地二阶段项目投放，乙烯消耗量超百万吨
原料：丙烷与油价关联性较强
资料来源：百川盈孚，Wind，HTI
原油通过常减压蒸馏装置，催化裂化装置，气分装置后，得到丙烷等产品。
丙烷价格与油价关联性较强，根据wind数据计算，2012-2023年丙烷价格与油价相关系数为93%
丙烷(冷冻货)CFR华东（左轴，美元吨）
布伦特原油（右轴，美元桶）
资料来源：百川盈孚，HTI
产品：主要用于消费、地产，受益需求复苏
C3产品应用领域与消费和地产密切相关，在消费复苏过程中有望涨价：
丙烯酸：60%用于生产丙烯酸酯，主要用于建筑涂料苯丙乳液、纯丙乳液、包装用胶带母卷等产品
生产；20%用于SAP，主要用于医疗卫生行业纸尿裤、卫生巾、工业堵漏材料等产品生产。
聚丙烯：37%用于生产拉丝料，34%用于生产注塑料。12%用于生产薄膜。
图C3产品与消费、地产密切相关
建筑涂料苯丙乳液、纯丙
乳液、包装用胶带母卷等
医疗卫生行业纸尿裤、卫生
C3产品价差分位数约为10%左右，处于底部
资料来源：Wind，HTI
（元吨）价格分位数当前价-最低价最高价-当前价
（元吨）价差分位数
丙烯酸丁酯-丙烷-丁醇2013-04-01 2023-10-18
丙烯酸乙酯-丙烷-乙醇2013-04-01 2023-10-18
丙烯酸甲酯-丙烷-甲醇2013-04-01 2023-10-18
表C3产品价格情况（元吨）
表C3产品价差情况（元吨）
截止2023年10月18日，C3产品中丙烯酸价差分位数为11%，丙烯酸酯甲酯价差分位数为38%，丙
烯酸乙酯价差分位数为14%，丙烯酸丁酯价差分位数为8%，聚丙烯价差为12%，均处于较低水平
截止2023年10月18日，丙烯酸价差为1396元吨，比中位数低68%；丙烯酸甲酯价差为4964元吨
，比中位数低17%；丙烯酸乙酯价差为7124元吨，比中位数低8%；丙烯酸丁酯价差为934元吨，
比中位数低65%；聚丙烯价差为880元吨，比中位数低72%
C3产品价差存在较大修复空间
图丙烯酸及酯价差（元吨）
资料来源：Wind，HTI
聚丙烯：2023Q3价差水平低于历史均值1323元吨，比历史均值(2783元吨）低48%。
丙烯酸：2023Q3价差水平低于历史均值1927元吨，比历史均值(4591元吨）低42%。
丙烯酸丁酯：2023Q3价差水平低于历史均值1472元吨，比历史均值(3205元吨）低46%。
丙烯酸丁酯-丙烷-丁醇价差
产品：库存水平处于历史平均水平
图丙烯酸、丙烯酸丁酯难以储存，库存较少
资料来源：Wind，百川盈孚，HTI
丙烯酸及酯：截止2023年10月19日，丙烯酸行业库存059万吨（历史平均水平050万吨），丙烯
酸丁酯行业库存035万吨（历史平均水平029万吨），均处于历史平均水平。
聚丙烯：截止2023年10月19日，聚丙烯行业库存天数为762天，低于历史平均水平（历史平均水
聚丙烯库存天数（天）
聚丙烯产能投放较多，丙烯酸及酯产能投放较少
资料来源：百川盈孚，HTI
图丙烯酸及丙烯酸丁酯2023年新增产能较少
埃克森美孚(惠州)化工
万华化学(烟台)石化
表2023年聚丙烯产能投放较多
预计新增产能（万吨）
预计新增产能（万吨）
巴斯夫一体化基地(广东)
据百川盈孚不完全统计：
聚丙烯：2023年新增产能1260吨，占2022年中国消费量的38%。
丙烯酸：2023年新增产能18万吨，占2022年中国消费量的7%。
丙烯酸丁酯：：2023年新增产能8万吨，占2022年中国消费量的6%。
我们预计公司20232025年归母净利润分别为4581亿元、6234亿元、8691亿元，EPS分别为
136元、185元、258元，按照2023年EPS以及14倍PE，对应目标价1904元，维持优于大市
注：收盘价为2023年10月23日价格，EPS为wind一致预期。资料来源：Wind，HTI
公司PE估值中枢在16倍左右
图2018-2023公司估值中枢在16倍
资料来源：wind，HTI
资料来源：wind，HTI
现金流量表（百万元）
资产负债表（百万元）
资料来源：wind，HTI
原油价格趋势性回落。
石化产品价格、价差下降。
投资项目进度低于预期。
附录——公司主要产品表观消费量情况
资料来源：百川盈孚，HTI
聚丙烯：2018-2022年，中国聚丙烯表观消费量从2502万吨上升至3244万吨，CAGR670%，进
口依存度从18%下降至14%。
丙烯酸：2018-2022年，中国丙烯酸表观消费量从161万吨上升至241万吨，CAGR1054%，进
口依存度较低，在1%-3%之间波动。
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
附录——公司主要产品表观消费量情况
资料来源：百川盈孚，HTI
图环氧乙烷表观消费量（无进口）
丙烯酸丁酯：2021-2022年，中国丙烯酸丁酯表观消费量从105万吨上升至130万吨，进口依存度从
059%上升至123%。
环氧乙烷：2019-2022年，中国环氧乙烷表观消费量从361万吨上升至508万吨，CAGR1213% 。
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
表观消费量（左轴，万吨）
附录——公司主要产品表观消费量情况
资料来源：百川盈孚，HTI
聚乙烯：2018-2022年，中国聚乙烯表观消费量保持在3000-4000万吨之间，进口依存度从48%下
苯乙烯：2018-2022年，中国苯乙烯表观消费量保持在1100-1400万吨之间，进口依存度从26%下
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
附录——公司主要产品表观消费量情况
资料来源：百川盈孚，HTI
乙醇胺：2019-2022年，中国乙醇胺表观消费量保持在50万吨左右，进口依存度从37%下降至26%
碳酸二甲酯：2018-2022年，由于锂电行业蓬勃发展，中国碳酸二甲酯表观消费量从32万吨上升至
85万吨，CAGR28% ，进口依存度从21%下降至5%。
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
进口量（万吨，左轴）
出口量（万吨，左轴）
表观消费量（万吨，左轴）
APPENDIX 2
IMPORTANT DISCLOSURES
This research report is distributed by Haitong International a global brand name for the equity research teams of Haitong International Research Limited (HTIRL) Haitong Securities India Private Limited
(HSIPL) Haitong International Japan KK (HTIJKK) Haitong International Securities Company Limited (HTISCL) and any other members within the Haitong International Securities Group of Companies
(HTISG) each authorized to engage in securities activities in its respective jurisdiction
我，Junjun Zhu，在此保证（i）本研究报告中的意见准确反映了我们对本研究中提及的任何或所有目标公司或上市公司的个人观点，并且（ii）我的报酬中没有任何部分与本研究报告中表达
will not deal in or trade any securities in respect of the issuer that I review within 3 business days after the research report is published
我，Xin Hu，在此保证（i）本研究报告中的意见准确反映了我们对本研究中提及的任何或所有目标公司或上市公司的个人观点，并且（ii）我的报酬中没有任何部分与本研究报告中表达的具
will not deal in or trade any securities in respect of the issuer that I review within 3 business days after the research report is published
我，Borong Li，在此保证（i）本研究报告中的意见准确反映了我们对本研究中提及的任何或所有目标公司或上市公司的个人观点，并且（ii）我的报酬中没有任何部分与本研究报告中表达的
will not deal in or trade any securities in respect of the issuer that I review within 3 business days after the research report is published
APPENDIX 2
利益冲突披露Conflict of Interest Disclosures
作为主经纪商的新三板上市、目标配售和并购项目。
Haitong Securities Co Ltd andor its subsidiaries (collectively the Haitong) have a role in investment banking projects of 002221CH within the past 12 months The investment banking projects include 1 IPO projects in which Haitong acted as pre-listing tutor sponsor or lead-underwriter 2
equity or debt refinancing projects of 002221CH for which Haitong acted as sponsor lead-underwriter or financial advisor 3 listing by introduction in the new three board target placement MA projects in which Haitong acted as lead-brokerage firm
002221CH目前或过去12个月内是海通的投资银行业务客户。
002221CH iswas an investment bank clients of Haitong currently or within the past 12 months
002221CH and 000703CH arewere a client of Haitong currently or within the past 12 months The client has been provided for non-investment-banking securities-related services
APPENDIX 2
评级定义（从2020年7月1日开始执行）：
海通国际（以下简称HTI）采用相对评级系统来为投资者推荐我们覆盖的公司：优于大市、中性或弱于大市。投资者应仔细阅读HTI的评级
议。投资者的买卖股票的决策应基于各自情况（比如投资者的现有持仓）以及其他因素。
优于大市，未来12-18个月内预期相对基准指数涨幅在10%以上，基准定义如下
中性，未来12-18个月内预期相对基准指数变化不大，基准定义如下。根据FINRANYSE的评级分布规则，我们会将中性评级划入持有这一类
弱于大市，未来12-18个月内预期相对基准指数跌幅在10%以上，基准定义如下
各地股票基准指数：日本 TOPIX 韩国 KOSPI 台湾 TAIEX 印度 Nifty100 美国 SP500 其他所有中国概念股 MSCI China
Ratings Definitions (from 1 Jul 2020)
Investors should carefully read the definitions of all ratings used in Haitong International Research In addition since Haitong International Research
not infer the contents from the rating alone In any case ratings (or research) should not be used or relied upon as investment advice An investors
decision to buy or sell a stock should depend on individual circumstances (such as the investors existing holdings) and other considerations
Analyst Stock Ratings
Outperform The stocks total return over the next 12-18 months is expected to exceed the return of its relevant broad market benchmark as indicated
Neutral The stocks total return over the next 12-18 months is expected to be in line with the return of its relevant broad market benchmark as
indicated below For purposes only of FINRANYSE ratings distribution rules our Neutral rating falls into a hold rating category
Underperform The stocks total return over the next 12-18 months is expected to be below the return of its relevant broad market benchmark as
indicated below
Benchmarks for each stocks listed region are as follows Japan  TOPIX Korea  KOSPI Taiwan  TAIEX India  Nifty100 US  SP500 for all other
China-concept stocks  MSCI China
APPENDIX 2
评级分布Rating Distribution
APPENDIX 2
截至2023年9月30日海通国际股票研究评级分布
在每个评级类别里投资银行客户所占的百分比。
上述分布中的买入，中性和卖出分别对应我们当前优于大市，中性和落后大市评级。
只有根据FINRANYSE的评级分布规则，我们才将中性评级划入持有这一类别。请注意在上表中不包含非评级的股票。
此前的评级系统定义（直至2020年6月30日）：
买入，未来12-18个月内预期相对基准指数涨幅在10%以上，基准定义如下
中性，未来12-18个月内预期相对基准指数变化不大，基准定义如下。根据FINRANYSE的评级分布规则，我们会将中性评级划入持有这一类
卖出，未来12-18个月内预期相对基准指数跌幅在10%以上，基准定义如下
各地股票基准指数：日本 TOPIX 韩国 KOSPI 台湾 TAIEX 印度 Nifty100 其他所有中国概念股 MSCI China
Haitong International Equity Research Ratings Distribution as of Sep 30 2023
HTI Equity Research Coverage
IB clients
Percentage of investment banking clients in each rating category
BUY Neutral and SELL in the above distribution correspond to our current ratings of Outperform Neutral and Underperform
For purposes only of FINRANYSE ratings distribution rules our Neutral rating falls into a hold rating category Please note that stocks with an NR
designation are not included in the table above
Previous rating system definitions (until 30 Jun 2020)
BUY The stocks total return over the next 12-18 months is expected to exceed the return of its relevant broad market benchmark as indicated below
NEUTRAL The stocks total return over the next 12-18 months is expected to be in line with the return of its relevant broad market benchmark as
indicated below For purposes only of FINRANYSE ratings distribution rules our Neutral rating falls into a hold rating category
SELL The stocks total return over the next 12-18 months is expected to be below the return of its relevant broad market benchmark as indicated
Benchmarks for each stocks listed region are as follows Japan  TOPIX Korea  KOSPI Taiwan  TAIEX India  Nifty100 for all other China-concept
stocks  MSCI China
APPENDIX 2
海通国际非评级研究：海通国际发布计量、筛选或短篇报告，并在报告中根据估值和其他指标对股票进行排名，或者基于可能的估值倍数提出建议价格。
这种排名或建议价格并非为了进行股票评级、提出目标价格或进行基本面估值，而仅供参考使用。
Haitong International Non-Rated Research Haitong International publishes quantitative screening or short reports which may rank stocks according to valuation and
other metrics or may suggest prices based on possible valuation multiples Such rankings or suggested prices do not purport to be stock ratings or target prices or
fundamental values and are for information only
Haitong International Coverage of A-Shares Haitong International may cover and rate A-Shares that are subject to the Hong Kong Stock Connect scheme with
A-Shares for distribution in mainland China However the rating system employed by HS differs from that used by HTI and as a result there may be a difference in the
HTI and HS ratings for the same A-share stocks
Haitong International Quality 100 A-share (Q100) Index HTIs Q100 Index is a quant product that consists of 100 of the highest-quality A-shares under coverage at
APPENDIX 2
盟浪义利（FIN-ESG）数据通免责声明条款：在使用盟浪义利（FIN-ESG）数据之前，请务必仔细阅读本条款并同意本声明：
第一条义利（FIN-ESG）数据系由盟浪可持续数字科技有限责任公司（以下简称本公司）基于合法取得的公开信息评估而成，本公司对信息的准确性及
完整性不作任何保证。对公司的评估结果仅供参考，并不构成对任何个人或机构投资建议，也不能作为任何个人或机构购买、出售或持有相关金融产品的
依据。本公司不对任何个人或机构投资者因使用本数据表述的评估结果造成的任何直接或间接损失负责。
第二条盟浪并不因收到此评估数据而将收件人视为客户，收件人使用此数据时应根据自身实际情况作出自我独立判断。本数据所载内容反映的是盟浪在最
初发布本数据日期当日的判断，盟浪有权在不发出通知的情况下更新、修订与发出其他与本数据所载内容不一致或有不同结论的数据。除非另行说明，本
数据（如财务业绩数据等）仅代表过往表现，过往的业绩表现不作为日后回报的预测。
第三条本数据版权归本公司所有，本公司依法保留各项权利。未经本公司事先书面许可授权，任何个人或机构不得将本数据中的评估结果用于任何营利性
目的，不得对本数据进行修改、复制、编译、汇编、再次编辑、改编、删减、缩写、节选、发行、出租、展览、表演、放映、广播、信息网络传播、摄
制、增加图标及说明等，否则因此给盟浪或其他第三方造成损失的，由用户承担相应的赔偿责任，盟浪不承担责任。
第四条如本免责声明未约定，而盟浪网站平台载明的其他协议内容（如盟浪网站用户注册协议盟浪网用户服务（含认证）协议盟浪网隐私政
策等）有约定的，则按其他协议的约定执行；若本免责声明与其他协议约定存在冲突或不一致的，则以本免责声明约定为准。
SusallWave FIN-ESG Data Service Disclaimer Please read these terms and conditions below carefully and confirm your agreement and acceptance with these terms
before using SusallWave FIN-ESG Data Service
1 FIN-ESG Data is produced by SusallWave Digital Technology Co Ltd (In short SusallWave)s assessment based on legal publicly accessible information SusallWave
individual or institution and not for basis of purchasing selling or holding any relative financial products We will not be liable for any direct or indirect loss of any
individual or institution as a result of using SusallWave FIN-ESG Data
2 SusallWave do not consider recipients as customers for receiving these data When using the data recipients shall make your own independent judgment according
to your practical individual status The contents of the data reflect the judgment of us only on the release day We have right to update and amend the data and
release other data that contains inconsistent contents or different conclusions without notification Unless expressly stated the data (eg financial performance data)
represents past performance only and the past performance cannot be viewed as the prediction of future return
of individual or institution can use these data for any profitable purpose Besides none of individual or institution can take actions such as amendment replication
transmission shooting adding icons and instructions If any loss of SusallWave or any third-party is caused by those actions users shall bear the corresponding
4 If any term is not contained in this disclaimer but written in other agreements on our website (eg User Registration Protocol of SusallWave Website User Service
(including authentication) Agreement of SusallWave Website Privacy Policy of Susallwave Website) it should be executed according to other agreements If there is
any difference between this disclaim and other agreements this disclaimer shall be applied
APPENDIX 2
Private Limited（HTSIPL）所发行，包括制作及发布涵盖BSE Limited（BSE）和National Stock Exchange of India Limited（NSE）上市公司（统称为印
正确性不做任何明示或暗示的声明或保证。本文件中所有观点均截至本报告日期，如有更改，恕不另行通知。本文件仅供参考使用。文件中提及的任何
的结果。某些特定交易，包括设计金融衍生工具的，有产生重大风险的可能性，因此并不适合所有的投资者。您还应认识到本文件中的建议并非为您量
融和其他方面的专业顾问，以期在投资之前评估该项建议是否适合于您。若由于使用本文件所载的材料而产生任何直接或间接的损失，HTISG及其董事、
雇员或代理人对此均不承担任何责任。
有长仓或短仓以及进行买卖。HTISG的销售员、交易员和其他专业人士均可向HTISG的相关客户和公司提供与本文件所述意见相反的口头或书面市场评论
意见或交易策略。HTISG可做出与本文件所述建议或意见不一致的投资决策。但HTIRL没有义务来确保本文件的收件人了解到该等交易决定、思路或建
APPENDIX 2
For research reports on non-Indian securities The research report is issued by Haitong International Research Limited (HTIRL) a wholly owned subsidiary of
Haitong International Securities Group Limited (HTISGL) and a licensed corporation to carry on Type 4 regulated activity (advising on securities) for the purpose of
the Securities and Futures Ordinance (Cap 571) of Hong Kong with the assistance of Haitong International (Japan) KK (HTIJKK) a wholly owned subsidiary of
HTISGL and which is regulated as an Investment Adviser by the Kanto Finance Bureau of Japan
and Exchange Board of India (SEBI) registered Stock Broker Merchant Banker and Research Analyst that inter alia produces and distributes research reports
covering listed entities on the BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE) (collectively referred to as Indian Exchanges) HSIPL
was acquired and became part of the Haitong International Securities Group of Companies (HTISG) on 22 December 2016
All the research reports are globally branded under the name Haitong International and approved for distribution by Haitong International Securities Company
Limited (HTISCL) andor any other members within HTISG in their respective jurisdictions
representation or warranty express or implied is made by HTIRL HTISCL HSIPL HTIJKK or any other members within HTISG from which this research report may
research report may not be eligible for purchase or sale in some jurisdictions If an investment product is denominated in a currency other than an investors home
currency a change in exchange rates may adversely affect the investment Past performance is not necessarily indicative of future results Certain transactions
research report are not tailor-made for you The analyst has not taken into account your unique financial circumstances such as your financial situation and risk
appetite You must therefore analyze and should where applicable consult your own legal tax accounting financial and other professional advisers to evaluate
direct or consequential loss arising from any use of the materials contained in this research report
APPENDIX 2
HTISG and our affiliates officers directors and employees excluding the analysts responsible for the content of this document will from time to time have long or
short positions in act as principal in and buy or sell the securities or derivatives if any referred to in this research report Sales traders and other professionals of
any recipient of this research report
and avoidance of conflicts of interest with respect to Research
Non US Analyst Disclosure The HTI analyst(s) listed on the cover of this Research is (are) not registered or qualified as a research analyst with FINRA and are not
a research analyst
APPENDIX 2
告的收件人就研究报告中产生或与之相关的任何事宜请联系HTISCL销售人员。
美国投资者的通知事项：本研究报告由HTIRL，HSIPL或HTIJKK编写。HTIRL，HSIPL，HTIJKK以及任何非HTISG美国联营公司，均未在美国注册，因此不受美
投资者（Major US Institutional Investor）和机构投资者（US Institutional Investors）。在向美国机构投资者分发研究报告时，Haitong
相关金融工具买卖的交易，只能通过HTI USA。HTI USA位于340 Madison Avenue 12th Floor New York NY 10173，电话（212）351-6050。HTI USA是在美国
于US Securities and Exchange Commission（SEC）注册的经纪商，也是Financial Industry Regulatory Authority Inc（FINRA）的成员。HTIUSA不负责编写
Haitong International Securities (USA) Inc
340 Madison Avenue 12th Floor
New York NY 10173
APPENDIX 2
DISTRIBUTION AND REGIONAL NOTICES
Except as otherwise indicated below any Recipient wishing to discuss this research report or effect any transaction in any security discussed in HTIs research should
contact the Haitong International salesperson in their own country or region
Notice to Hong Kong investors The research report is distributed by Haitong International Securities Company Limited (HTISCL) which is a licensed corporation to
carry on Type 1 regulated activity (dealing in securities) in Hong Kong This research report does not constitute a solicitation or an offer of securities or an invitation
to the public within the meaning of the SFO This research report is only to be circulated to Professional Investors as defined in the SFO This research report has
not been reviewed by the Securities and Futures Commission You should not make investment decisions solely on the basis of the information contained in this
research report Recipients of this research report are to contact HTISCL salespersons in respect of any matters arising from or in connection with the research
Notice to US investors As described above this research report was prepared by HTIRL HSIPL or HTIJKK Neither HTIRL HSIPL HTIJKK nor any of the non US
HTISG affiliates is registered in the United States and therefore is not subject to US rules regarding the preparation of research reports and the independence of
research analysts
This research report is provided for distribution to major US institutional investors and US institutional investors in reliance on the
exemption from registration provided by Rule 15a-6 of the US Securities Exchange Act of 1934 as amended When distributing research reports to US
institutional investors HTI USA will accept the responsibilities for the content of the reports Any US recipient of this research report wishing to effect any
transaction to buy or sell securities or related financial instruments based on the information provided in this research report should do so only through Haitong
International Securities (USA) Inc (HTI USA) located at 340 Madison Avenue 12th Floor New York NY 10173 USA telephone (212) 351 6050 HTI USA is a broker-
dealer registered in the US with the US Securities and Exchange Commission (the SEC) and a member of the Financial Industry Regulatory Authority Inc
(FINRA) HTI USA is not responsible for the preparation of this research report nor for the analysis contained therein Under no circumstances should any US
recipient of this research report contact the analyst directly or effect any transaction to buy or sell securities or related financial instruments directly through HSIPL
HTIRL or HTIJKK The HSIPL HTIRL or HTIJKK analyst(s) whose name appears in this research report is not registered or qualified as a research analyst with FINRA and
research analyst account Investing in any non-US securities or related financial instruments (including ADRs) discussed in this research report may present certain
risks The securities of non-US issuers may not be registered with or be subject to US regulations Information on such non-US securities or related financial
related financial instruments All inquiries by US recipients should be directed to
APPENDIX 2
Haitong International Securities (USA) Inc
340 Madison Avenue 12th Floor
New York NY 10173
Attn Sales Desk at (212) 351 6050
中华人民共和国的通知事项：在中华人民共和国（下称中国，就本报告目的而言，不包括香港特别行政区、澳门特别行政区和台湾）只有根据适用
的中国法律法规而收到该材料的人员方可使用该材料。并且根据相关法律法规，该材料中的信息并不构成在中国从事生产、经营活动。本文件在中
USA）予以实施，该公司是一家根据National Instrument 31-103 Registration Requirements Exemptions and Ongoing Registrant Obligations（NI 31-103）的
规定得到国际交易商豁免（International Dealer Exemption ）的交易商，位于艾伯塔省、不列颠哥伦比亚省、安大略省和魁北克省。在加拿大，该
National Instrument 45-106 Prospectus Exemptions第11节或者Securities Act (Ontario)第733(1)节所规定的认可投资者（Accredited Investor），或者在
适用情况下National Instrument 31-103第11节所规定的许可投资者（Permitted Investor）。
新加坡投资者的通知事项：本研究报告由Haitong International Securities (Singapore) Pte Ltd（HTISSPL）公司注册编号201311400G 于新加坡提供。
（第289章）第4A条项下规定的机构投资者。对于因本研究报告而产生的或与之相关的任何问题，本研究报告的收件人应通过以下信息与HTISSPL联系
Haitong International Securities (Singapore) Pte Ltd
50 Raffles Place 33-03 Singapore Land Tower Singapore 048623
APPENDIX 2
和交易法（ FIEL））第61（1）条，第17-11（1）条的执行及相关条款）。
户发布。任何投资或与本报告相关的投资行为只面对此类专业客户。没有投资经验或相关投资经验的客户不得依赖本报告。Haitong International Securities
Company Limited的分支机构的净长期或短期金融权益可能超过本研究报告中提及的实体已发行股本总额的05。特别提醒有些英文报告有可能此前已经
通过中文或其它语言完成发布。
澳大利亚投资者的通知事项：Haitong International Securities (Singapore) Pte Ltd Haitong International Securities Company Limited和Haitong International
免除了根据2001年公司法在澳大利亚为批发客户提供金融服务时海通国际需持有澳大利亚金融服务许可的要求。ASIC的规章副本可在以下网站获
Private Limited（HTSIPL）所发布，包括制作及发布涵盖BSE Limited（BSE）和National Stock Exchange of India Limited（NSE）（统称为印度交易
研究机构名称 Haitong Securities India Private Limited
841 Senapati Bapat Marg Elphinstone Road Mumbai 400 013 India
请注意，SEBI 授予的注册和NISM 的认证并不保证中介的表现或为投资者提供任何回报保证。
本项研究仅供收件人使用，未经海通国际的书面同意不得予以复制和再次分发。
APPENDIX 2
Peoples Republic of China (PRC) In the PRC the research report is directed for the sole use of those who receive the research report in accordance with the
applicable PRC laws and regulations Further the information on the research report does not constitute production and business activities in the PRC under
relevant PRC laws This research report does not constitute a public offer of the security whether by sale or subscription in the PRC Further no legal or natural
persons of the PRC may directly or indirectly purchase any of the security or any beneficial interest therein without obtaining all prior PRC government approvals or
Notice to Canadian Investors Under no circumstances is this research report to be construed as an offer to sell securities or as a solicitation of an offer to buy
securities in any jurisdiction of Canada Any offer or sale of the securities described herein in Canada will be made only under an exemption from the requirements to
file a prospectus with the relevant Canadian securities regulators and only by Haitong International Securities (USA) Inc a dealer relying on the international dealer
exemption under National Instrument 31-103 Registration Requirements Exemptions and Ongoing Registrant Obligations (NI 31-103) in Alberta British Columbia
Ontario and Quebec This research report is not and under no circumstances should be construed as a prospectus an offering memorandum an advertisement or a
report the information contained herein or the merits of the securities described herein and any representation to the contrary is an offence Upon receipt of this
research report each Canadian recipient will be deemed to have represented that the investor is an accredited investor as such term is defined in section 11 of
National Instrument 45-106 Prospectus Exemptions or in Ontario in section 733(1) of the Securities Act (Ontario) as applicable and a permitted client as such
term is defined in section 11 of NI 31-103 respectively
Notice to Singapore investors This research report is provided in Singapore by or through Haitong International Securities (Singapore) Pte Ltd (HTISSPL) Co Reg
No 201311400G HTISSPL is an Exempt Financial Adviser under the Financial Advisers Act (Cap 110) (FAA) to (a) advise on securities units in a collective investment
scheme exchange-traded derivatives contracts and over-the-counter derivatives contracts and (b) issue or promulgate research analyses or research reports on
securities exchange-traded derivatives contracts and over-the-counter derivatives contracts This research report is only provided to institutional investors within
the meaning of Section 4A of the Securities and Futures Act (Cap 289) Recipients of this research report are to contact HTISSPL via the details below in respect of
any matters arising from or in connection with the research report
APPENDIX 2
Haitong International Securities (Singapore) Pte Ltd
10 Collyer Quay 19-01 - 19-05 Ocean Financial Centre Singapore 049315
Telephone (65) 6536 1920
Notice to Japanese investors This research report is distributed by Haitong International Securities Company Limited and intended to be distributed to Financial
Services Providers or Registered Financial Institutions engaged in investment management (as defined in the Japan Financial Instruments and Exchange Act (FIEL)
Art 61(1) Order for Enforcement of FIEL Art 17-11(1) and related articles)
Notice to UK and European Union investors This research report is distributed by Haitong International Securities Company Limited This research is directed at
persons having professional experience in matters relating to investments Any investment or investment activity to which this research relates is available only to
such persons or will be engaged in only with such persons Persons who do not have professional experience in matters relating to investments should not rely on this
research Haitong International Securities Company Limiteds affiliates may have a net long or short financial interest in excess of 05% of the total issued share
capital of the entities mentioned in this research report Please be aware that any report in English may have been published previously in Chinese or another
Notice to Australian investors The research report is distributed in Australia by Haitong International Securities (Singapore) Pte Ltd Haitong International Securities
Company Limited and Haitong International Securities (UK) Limited in reliance on ASIC Class Order 031102 031103 or 031099 respectively which exempts those
HTISG entities from the requirement to hold an Australian financial services license under the Corporations Act 2001 in respect of the financial services it provides to
Haitong International Securities (Singapore) Pte Ltd Haitong International Securities Company Limited and Haitong International Securities (UK) Limited are
regulated under foreign laws and regulatory requirements which are different from the laws applying in Australia
Board of India (SEBI) registered Stock Broker Merchant Banker and Research Analyst that inter alia produces and distributes research reports covering listed
entities on the BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE) (collectively referred to as Indian Exchanges)
Name of the entity Haitong Securities India Private Limited
SEBI Research Analyst Registration Number INH000002590
APPENDIX 2
Address  1203A Floor 12A Tower 2A One World Center
841 Senapati Bapat Marg Elphinstone Road Mumbai 400 013 India
Please note that Registration granted by SEBI and Certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns
to investors
This research report is intended for the recipients only and may not be reproduced or redistributed without the written consent of an authorized signatory of HTISG
Copyright Haitong International Securities Group Limited 2019 All rights reserved